GOSSAMER BIO INC (GOSS)

US38341P1021 - Common Stock

0.668  0 (-0.3%)

After market: 0.7 +0.03 (+4.79%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
173.76M218.52M216.04M210.58M182.54M
Research and Development
135.30M170.92M170.27M160.85M143.40M
Selling, General, and Administrative Expenses
38.45M45.81M44.08M48.33M38.24M
Operating Income
-173.76M-218.52M-216.04M-210.58M-182.54M
Interest Income/Expense
-11.51M-12.30M-18.68M-9.22MN/A
Other Income/Expense
15.46M1.51M800.00K-170.00K5.83M
Non Recurring Items
-10.00M-70.00K-80.00K-23.38M-3.60M
Income Before Taxes
-179.82M-229.38M-234.00M-243.36M-180.31M
Net Income
-179.82M-229.38M-234.00M-243.36M-180.31M
EBITDA
-172.15M-216.69M-214.30M-209.17M-181.62M
 
Per Share Data
EPS Diluted Total Ops
-1.18-2.71-3.13-3.55-3.29
Non GAAP EPS
-1.39-2.74-3.12-3.55-3.33
 
Statistics

All data in USD

Charts